Back to FATE
Redmile Group, LLC FATE Position History
Fate Therapeutics, Inc. • Healthcare
Quarters held
4
Latest value
$30.5M
Q3 2026
Peak value
$34.8M
First seen
Q4 2025
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q4 2025 | $12.6M |
| Q1 2026 | $15.4M |
| Q2 2026 | $34.8M |
| Q3 2026 | $30.5M |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q3 2026 | $30.5M | 12.87M | — | — |
| Q2 2026 | $34.8M | 12.87M | — | — |
| Q1 2026 | $15.4M | 12.87M | — | — |
| Q4 2025 | $12.6M | 12.87M | — | — |
Other funds holding FATE
$62.6M
$39.7M
$35M
$32.8M
$31.3M